{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Klotho, Peptides & Limitless Longevity \u2014 Dr. Alex Grinberg & Dr. Dave Jenkins","description":" These two doctors are building a clinic where the most advanced longevity therapies have no limits. Dr. Alexander Grinberg (Infinity Epigenetics, San Francisco) and Dr. Dave Jenkins (Bredesen-trained, 40+ years clinical experience) are combining peptide therapy, regenerative medicine, and personalised protocols at a level most people don't know exists. From Klotho protein restoring cognitive function in head injury patients to mitochondrial peptides that can rescue dying cells \u2014 this conversation covers the cutting edge of what's actually possible right now. About the Guests Dr. Alexander Grinberg MD is a physician, immunologist, and peptide therapy specialist practicing in San Francisco. He holds a fellowship from the Moscow Immunology Institute and consults internationally on advanced customised longevity protocols. He runs Infinity Epigenetics and teaches physicians in high-end integration of peptides, regenerative medicine, and genetic therapies. Dr. Dave Jenkins is a New Zealand-trained physician with 40+ years of clinical experience specialising in metabolic and neurological health. He is Bredesen Protocol (ReCODE) trained and runs a longevity clinic in Bali. He co-developed a Type 2 Diabetes reversal program now being published and reviewed by NZ's top diabetic specialists. In this episode Why Klotho protein may be one of the most powerful longevity interventions available \u2014 and the different delivery forms (protein injection, peptide fragments, gene therapy) Dr. Dave's clinical Klotho results: a doctor with chronic head injury returning to practice, and his own memory score jumping from the 66th to the 97th percentile in six weeks How mitochondrial peptides (MOTS-c, SS-31, Humanin) work and why dosing wrong can be dangerous \u2014 especially in autoimmune and cancer history cases The case for micro-dosing peptides and why skin testing should come first Personalised medicine taken to its extreme: harvesting a patient's own cells, expanding them in culture, and running accelerated longevity and cancer resilience tests before any intervention Why peptide purity and sourcing is a serious safety concern \u2014 and what the clinic will do differently The vision for a Pacific Island longevity clinic offering therapies unavailable in the US, EU, NZ, or Australia \u2014 with a social impact mission to address metabolic disease in local populations Off-label repurposed drugs for cancer (metformin, ivermectin, doxycycline, mebendazole) and why the regulatory environment matters How custom peptides designed from a patient's own genome could replace pharmaceuticals entirely Resources mentioned Infinity Epigenetics \u2014 infinityepigenetics.com Dr. Dave Jenkins \u2014  \ud83c\udf10 https:\/\/youngerbyscience.com\/ \ud83c\udf10 https:\/\/theendofalzheimers.com ","author_name":"Pushing The Limits","author_url":"https:\/\/www.lisatamati.com","html":"